Drs. Bruijnzeel & Setlow Awarded NIH New R21 Grant

Adrie Bruijnzeel, PhD and Berry Setlow, PhD
Adrie Bruijnzeel, PhD and Berry Setlow, PhD

Adriaan Bruijnzeel, PhD and Barry Setlow, PhD have been awarded a National Institute of Health (NIH) R21 grant entitled, “Lasting Behavioral and Neuroimaging Consequences of Adolescent Exposure to Cannabis Smoke.” According to the NIH the R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. The scope of these awards are for new or extended discoveries toward new directions or applications. They are high risk reward studies that may lead to breakthroughs in a particular area, or result in novel techniques, agents, methodologies, models or applications that will impact biomedical, behavioral, or clinical research.

This award reflects their individual determination and commitment to excellence, and their prestigious work as a source of great pride for the UF College of Medicine. Please join us in congratulating Drs. Bruijnzeel and Setlow.